Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 22, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Type II Diabetes

Interventions

DRUG

PS1

PS1 will be provided as a 120 mg tablet with 25 mg active pharmaceutical ingredient.

DRUG

Placebo

Placebo will be provided as a 120 mg tablet.

Trial Locations (1)

RECRUITING

Mingche Liu, Taipei

All Listed Sponsors

lead

Pharmasaga Co. Ltd.

INDUSTRY